SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021905
Filing Date
2020-05-06
Accepted
2020-05-06 16:02:51
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 Q1 2020 10-Q srpt-10q_20200331.htm   iXBRL 10-Q 3169699
2 EX-31.1 srpt-ex311_8.htm EX-31.1 10532
3 EX-31.2 srpt-ex312_7.htm EX-31.2 11115
4 EX-32.1 srpt-ex321_9.htm EX-32.1 7179
5 EX-32.2 srpt-ex322_6.htm EX-32.2 7742
  Complete submission text file 0001564590-20-021905.txt   9294187

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA srpt-20200331.xsd EX-101.SCH 57776
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20200331_cal.xml EX-101.CAL 72297
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20200331_def.xml EX-101.DEF 148190
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20200331_lab.xml EX-101.LAB 389538
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20200331_pre.xml EX-101.PRE 284551
22 EXTRACTED XBRL INSTANCE DOCUMENT srpt-10q_20200331_htm.xml XML 1767836
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 20852541
SIC: 2834 Pharmaceutical Preparations